Oncology Central is a free platform that unites all aspects of oncology to support a multidisciplinary approach to progression of the field. We are dedicated to advancing oncology by offering access to trusted, engaging and insightful resources – including breaking news, peer-reviewed articles, webinars and articles from key opinion leaders.
By providing 360° perspectives on the latest advancements – encompassing the viewpoints of industry, clinicians, researchers, charities and patients alike – we are very proud to have established Oncology Central as a key resource for the global oncology community.
Future Science Group, founded in 2001, is independently owned. Future Science Group’s portfolio consists of two imprints, Future Medicine and Future Science. Both publish books and journals. In addition to this core publishing business, Future Science Group develops specialist community-driven websites. Key titles and sites include Oncology Central, Future Oncology and the award-winning Regenerative Medicine.
The aim of Future Science Group is to serve the advancement of clinical practice and drug research by enhancing the efficiency of communication among clinicians, researchers and decision-makers, and by providing innovative solutions to their information needs. This is achieved through a customer-centric approach, use of new technologies, products that deliver value-for-money and uncompromisingly high standards.
Sue S. Yom
Jan B. Vermorken
Nicholas A. Tritos